1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. HALOZYME THERAPEUTICS INC.

Halozyme Therapeutics Inc.

XNAS: HALO

Strong Performer, Getting Expensive
Download real time

65.16 0.84 (1.31%)

Near 52W High of $65.53

4.0M XNAS Volume

High volume today

XNAS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
32S
3W
2O
1T
8,049.4

Market Cap

High in industry
18.1

PE TTM

High in industry
0.3

PEG TTM

PEG TTM is less than 1
22.1

Price to Book

High in industry
0.0

Beta 1Year

Very Low volatility

Halozyme Therapeutics Inc. - HALO - stock price prediction, stock price target, analyst ratings from 10 analysts

Halozyme Therapeutics Inc. has a share price target of US$ 66, revenue growth forecast of 16.9%, and profit growth estimate of 25.1% for FY25, based on top 10 analyst calls.

Forecaster Screeners